Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Oncology Reports
|
May 20, 2011
Interferon-gamma enhances TNF sensitivity in A172 human glioblastoma cell line
G Cimoli, S Parodi, P Russo
Anti-Cancer Drugs
|
July 1, 1996
Interactions between taxol and camptothecin
D Debernardis, G Cimoli, S Parodi, et al.
Experimental Cell Research
|
May 8, 1998
Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities
E Schmitt, G Cimoli, A Steyaert, et al.
Cell Death and Differentiation
|
April 14, 1999
Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells
E Schmitt, A Steyaert, G Cimoli, et al.
International Journal of Oncology
|
March 17, 2001
HPV16-E6 enhances mitoxantrone sensitivity in a human ovarian cancer line: an isolated instance or a trend?
G Cimoli, M Valenti, C Ottoboni, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
January 1, 1997
The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation
E Schmitt, A T Sané, A Steyaert, et al.
Anticancer Research
|
September 1, 1992
Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells
G Cimoli, M Valenti, M Venturini, et al.
European Journal of Histochemistry : EJH
|
March 9, 1999
Muscarinic drugs affect cholinesterase activity and development of eye structures during early chick development
C Angelini, M Costa, F Morescalchi, et al.
Japanese Journal of Cancer Research : Gann
|
February 1, 1994
Circumvention of atypical multidrug resistance with tumor necrosis factor
G Cimoli, M Valenti, S Parodi, et al.
International Journal of Oncology
|
May 10, 2011
Tumor-necrosis-factor and DNA topoisomerase-ii inhibitors in human ovarian-cancer - potential role in chemotherapy
M Aluigi, D Debernardis, G Cimoli, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Oncology Reports
|
May 20, 2011
Interferon-gamma enhances TNF sensitivity in A172 human glioblastoma cell line
G Cimoli, S Parodi, P Russo
Anti-Cancer Drugs
|
July 1, 1996
Interactions between taxol and camptothecin
D Debernardis, G Cimoli, S Parodi, et al.
Experimental Cell Research
|
May 8, 1998
Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities
E Schmitt, G Cimoli, A Steyaert, et al.
Cell Death and Differentiation
|
April 14, 1999
Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells
E Schmitt, A Steyaert, G Cimoli, et al.
International Journal of Oncology
|
March 17, 2001
HPV16-E6 enhances mitoxantrone sensitivity in a human ovarian cancer line: an isolated instance or a trend?
G Cimoli, M Valenti, C Ottoboni, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
January 1, 1997
The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation
E Schmitt, A T Sané, A Steyaert, et al.
Anticancer Research
|
September 1, 1992
Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells
G Cimoli, M Valenti, M Venturini, et al.
European Journal of Histochemistry : EJH
|
March 9, 1999
Muscarinic drugs affect cholinesterase activity and development of eye structures during early chick development
C Angelini, M Costa, F Morescalchi, et al.
Japanese Journal of Cancer Research : Gann
|
February 1, 1994
Circumvention of atypical multidrug resistance with tumor necrosis factor
G Cimoli, M Valenti, S Parodi, et al.
International Journal of Oncology
|
May 10, 2011
Tumor-necrosis-factor and DNA topoisomerase-ii inhibitors in human ovarian-cancer - potential role in chemotherapy
M Aluigi, D Debernardis, G Cimoli, et al.
Page
of 3